PDA

View Full Version : Targeting IDO1 for cancer: Novel degraders show promise in preclinical studies


News
01-09-2026, 11:10 AM
Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these escape mechanisms.

More... (https://www.news-medical.net/news/20260109/Targeting-IDO1-for-cancer-Novel-degraders-show-promise-in-preclinical-studies.aspx)